Beckman Coulter's DxI 9000 Immunoassay Analyzer Honored at Premier, Inc.'s Annual Supplier Innovation Celebration
Beckman Coulter Diagnostics announced that its DxI 9000 Immunoassay Analyzer was honored at Premier, Inc.'s annual supplier Innovation Celebration. The analyzer boasts the highest throughput in the market and delivers the highest percentage of Six Sigma assays. A key feature is the Lumi-Phos PRO substrate, enabling measurement of analytes at the attomole level, equivalent to detecting a teaspoon of sugar in 100,000 Olympic-sized pools. This analytical sensitivity opens new possibilities for complementary diagnostics and revised claims for established assays. The recognition highlights Beckman Coulter's commitment to advancing healthcare through innovative solutions that enhance patient care, streamline operations, and improve efficiency.
Beckman Coulter Diagnostics ha annunciato che il suo DxI 9000 Immunoassay Analyzer è stato premiato durante la celebrazione annuale dell'innovazione dei fornitori di Premier, Inc. L'analizzatore vanta il massimo throughput sul mercato e offre la maggiore percentuale di saggi Six Sigma. Una caratteristica principale è il sotto-strato Lumi-Phos PRO, che consente la misurazione degli analiti a livello di attomole, equivalente a rilevare un cucchiaino di zucchero in 100.000 piscine olimpioniche. Questa sensibilità analitica apre nuove possibilità per diagnosi complementari e rivisitazioni di affermazioni per saggi consolidati. Il riconoscimento evidenzia l'impegno di Beckman Coulter nell'avanzare la sanità attraverso soluzioni innovative che migliorano la cura del paziente, semplificano le operazioni e aumentano l'efficienza.
Beckman Coulter Diagnostics anunció que su Analizador de Inmunoensayo DxI 9000 fue reconocido en la celebración anual de innovación de proveedores de Premier, Inc. El analizador cuenta con el mayor rendimiento en el mercado y proporciona el mayor porcentaje de ensayos Six Sigma. Una característica clave es el sustrato Lumi-Phos PRO, que permite la medición de analitos a nivel de attomole, equivalente a detectar una cucharadita de azúcar en 100,000 piscinas olímpicas. Esta sensibilidad analítica abre nuevas posibilidades para diagnósticos complementarios y revisiones de afirmaciones para ensayos establecidos. Este reconocimiento resalta el compromiso de Beckman Coulter con el avance de la atención médica a través de soluciones innovadoras que mejoran la atención al paciente, optimizan las operaciones y mejoran la eficiencia.
벡만 쿨터 진단부서는 자사의 DxI 9000 면역분석기가 프리미어 주식회사의 연례 공급업체 혁신 축제에서 수상했다고 발표했습니다. 이 분석기는 시장에서 가장 높은 처리량을 자랑하며 Six Sigma 분석의 가장 높은 비율을 제공합니다. 주요 특징은 Lumi-Phos PRO 기질로, 아날리트를 앳토몰 수준에서 측정할 수 있게 하며, 이는 100,000개의 올림픽 수영장에서 설탕 한 숟가락을 탐지하는 것에 해당합니다. 이러한 분석적 민감도는 보완 진단 및 기존 분석에 대한 수정된 주장에 대한 새로운 가능성을 열어줍니다. 인식은 환자 치료를 향상하고 운영을 간소화하며 효율성을 개선하는 혁신적인 솔루션을 통해 의료 발전에 대한 벡만 쿨터의 의지를 강조합니다.
Beckman Coulter Diagnostics a annoncé que son Analyseur d'immunodosage DxI 9000 a été honoré lors de la célébration annuelle de l'innovation des fournisseurs de Premier, Inc. L'analyseur présente le rendement le plus élevé sur le marché et offre le pourcentage le plus élevé d'analyses Six Sigma. Une caractéristique clé est le sous-strat Lumi-Phos PRO, qui permet de mesurer les analytes au niveau de l'attomole, équivalent à détecter une cuillerée de sucre dans 100 000 piscines de taille olympique. Cette sensibilité analytique ouvre de nouvelles possibilités pour des diagnostics complémentaires et des revendications révisées pour des tests établis. Cette reconnaissance met en lumière l'engagement de Beckman Coulter à faire progresser les soins de santé grâce à des solutions novatrices qui améliorent les soins aux patients, rationalisent les opérations et améliorent l'efficacité.
Beckman Coulter Diagnostics gab bekannt, dass sein DxI 9000 Immunoassay-Analyzer bei der jährlichen Innovationsfeier von Premier, Inc. ausgezeichnet wurde. Der Analyzer bietet den höchsten Durchsatz auf dem Markt und liefert den höchsten Prozentsatz an Six Sigma Assays. Ein wichtiges Merkmal ist das Lumi-Phos PRO Substrat, das die Messung von Analyten auf Attomole-Ebene ermöglicht, was der Detektion eines Teelöffels Zucker in 100.000 olympischen Schwimmbecken entspricht. Diese analytische Sensitivität eröffnet neue Möglichkeiten für ergänzende Diagnosen und überarbeitete Ansprüche für etablierte Tests. Die Anerkennung hebt das Engagement von Beckman Coulter hervor, das Gesundheitswesen durch innovative Lösungen voranzubringen, die die Patientenversorgung verbessern, die Abläufe optimieren und die Effizienz steigern.
- DxI 9000 Immunoassay Analyzer recognized at Premier's Innovation Celebration
- Highest throughput compared to any immunoassay analyzer on the market
- Delivers the highest percentage of Six Sigma assays in the market
- Lumi-Phos PRO substrate allows for attomole-level analytical sensitivity
- Potential for new complementary diagnostics and revised claims for established assays
- None.
With the highest throughput compared to any immunoassay analyzer on the market, Beckman Coulter's DxI 9000 Immunoassay Analyzer is filled with novel and innovative technologies with safeguards to prevent errors that could impact patient results, turnaround times, and costly errors. Furthermore the system delivers the highest percentage of Six Sigma assays on the market.
A transformative feature of the DxI 9000 Immunoassay analyzer is the Lumi-Phos PRO substrate which allows for a new standard in analytical sensitivity. Using this substrate, analytes can be measured at the attomole level which is the equivalent of a teaspoon of sugar in 100,000 Olympic-sized swimming pools. This analytical sensitivity opens the door to venture into complementary diagnostics in disease states with unmet needs or revisions of claims for established assays for new clinical use cases.
"Premier's supplier Innovation Celebration is a remarkable event, showcasing the pinnacle of ingenuity within the healthcare industry," said Kathleen Orland, Senior Vice President, Clinical Chemistry and Immunoassay General Manager, Beckman Coulter Diagnostics. "The celebration highlights transformative solutions that enhance patient care, streamline operations, and drive overall efficiency. Premier's dedication to recognizing these contributions elevates industry standards while encouraging continuous improvement and creative problem-solving, ultimately benefiting patients and healthcare providers alike."
"Premier proudly acknowledges Beckman Coulter's outstanding commitment to advancing healthcare," said Bruce Radcliff, Senior Vice President, Supply Chain at Premier. "Recognizing the DxI 9000 Analyzer at our 2024 Innovation Celebration reflects our shared mission to drive cost-efficiency, operational excellence and improved patient outcomes. We applaud Beckman Coulter for its invaluable contributions to healthcare."
Beckman Coulter was formally recognized on July 23, 2024,at Premier's annual Breakthroughs Conference and Exhibition. Premier, Inc. is a leading healthcare improvement and technology company that unites an alliance of more than 4,350
Follow and connect with Beckman Coulter via LinkedIn, Twitter, and Facebook
About Beckman Coulter. Inc.
A global leader in advanced diagnostics, Beckman Coulter has challenged convention to elevate the diagnostic laboratory's role in improving patient health for more than 80 years. Our mission is to Relentlessly Reimagine Healthcare, One Diagnosis at a Time – and we do this by applying the power of science, technology and the passion and creativity of our teams. Our diagnostic solutions are used in complex clinical testing, and are found in hospitals, reference laboratories and physician office settings around the globe. We exist to deliver smarter, faster diagnostic solutions that move the needle forward from what's now to what's next. We do this by accelerating care with an extensive clinical menu, scalable lab automation technologies, insightful clinical informatics, and optimize lab performance services. Beckman Coulter is part of the Danaher Corporation (NYSE: DHR) family of global science and technology companies. Headquartered in
© 2024 Beckman Coulter. All rights reserved. Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in
*Full name DxI 9000 Access Immunoassay Analyzer
View original content to download multimedia:https://www.prnewswire.com/news-releases/beckman-coulters-dxi-9000-immunoassay-analyzer-honored-at-premier-incs-annual-supplier-innovation-celebration-302206582.html
SOURCE Beckman Coulter Diagnostics
FAQ
What is the key feature of Beckman Coulter's DxI 9000 Immunoassay Analyzer?
How does the DxI 9000 Immunoassay Analyzer compare to other analyzers in the market?
What potential applications does the DxI 9000 Immunoassay Analyzer's sensitivity offer?
When and where was Beckman Coulter's DxI 9000 Immunoassay Analyzer recognized?
